枢经刮痧治疗肱骨外上髁炎的临床观察

Clinical Observation of Shujing Guasha Therapy for Lateral Epicondylitis of the Humerus

摘要: 目的：探讨枢经刮痧疗法对肱骨外上髁炎的临床疗效。方法：将60例肱骨外上髁炎的受试者随机数字表法随机分为2组，即治疗组30例，予枢经刮痧法治疗，对照组30例，予局部封闭疗法(局封)治疗。对照组采用局部封闭疗法，取曲安奈得40 mg和2%利多卡因100 mg，对痛点做常规封闭。应用视觉模拟评分法(VAS)和改良肘关节评分系统(HSS2)进行评分，观察治疗后疼痛缓解情况及疗程结束后临床疗效。结果：两组患者的VAS评分在治疗后均显著降低(P < 0.01)，其中治疗组的评分下降幅度更为明显。HSS2较治疗前均升高，治疗组升高更明显，治疗组总有效率90.00%，对照组总有效率76.66%，治疗组(枢经刮痧法)与对照组(局部封闭法)对肱骨外上髁炎的临床疗效相当(P > 0.05)。结论：枢经刮痧法治疗效果较局封闭法对肱骨外上髁炎好，且枢经刮痧法疗效更突出，效果更明显。枢经刮痧法与局部封闭疗法在改善肱骨外上髁炎患者疼痛和总体疗效上无统计学差异(P > 0.05)，但枢经刮痧在改善肘关节功能(HSS2评分)方面可能更具优势。

Abstract: Objective: To investigate the clinical efficacy of Shuijing Guasha therapy for lateral epicondylitis of the humerus. Methods: Sixty subjects with lateral epicondylitis were randomly assigned using a random number table into two groups: the treatment group (n = 30) received Shuijing Guasha therapy, and the control group (n = 30) received local injection therapy (LI). The control group received local injection therapy using 40 mg triamcinolone and 100 mg 2% lidocaine for routine block injection at the pain point. Visual Analogue Scale (VAS) and modified Hospital for Special Surgery 2 (HSS2) were used to assess pain relief and clinical efficacy after treatment. Results: VAS scores significantly decreased in both groups after treatment (P < 0.01), with a more pronounced reduction in the treatment group. HSS2 scores increased compared to pre-treatment levels in both groups, with a more pronounced increase in the treatment group. The overall effective rate was 90.00% in the treatment group and 76.66% in the control group. The clinical efficacy of the treatment group (Shuijing Guasha Therapy) and the control group (Local Injection Therapy) for lateral epicondylitis of the humerus was comparable (P > 0.05). Conclusion: Shuijing Guasha therapy demonstrates superior efficacy compared to local injection therapy for treating lateral epicondylitis of the humerus, exhibiting more pronounced therapeutic effects. There was no statistically significant difference between Shujing Guasha therapy and local injection therapy in improving pain and overall therapeutic efficacy in patients with lateral epicondylitis (P > 0.05). However, Shujing Guasha may demonstrate greater efficacy in improving elbow joint function (HSS2 score).